Skip to main content

Want to learn how federal programs are designed to fight fraud? Our new AI tool unlocks key insights from the Blueprint for Enhanced Program Integrity and GAO reports.

X
Skip to list of reports Filters

Date Range

Report Type

Report Category

Submitting Agency

Agency Reviewed

Related Organizations

Management Challenges

Any Recommendations

Any Open Recommendations

Reports

Search reports, investigative results, and agency plansShowing 261 - 267 of 267 results
Department of Justice OIG

U.S. Attorney for the District of South Dakota and IRS-CI Warn Taxpayers Against Fraud Schemes Related to COVID-19 Economic Impact Payments

Investigative Results |
Department of Justice OIG

U.S. Attorney’s Office Files Enforcement Action Against Chiropractor Promoting Fake COVID-19 Treatment

The U.S. Attorney’s Office for the Northern District of Texas has obtained a temporary restraining order preventing a DFW chiropractor from touting sham treatments for COVID-19.
Investigative Results |
Department of Justice OIG

Coronavirus Fraud Task Force Committed to Protecting U.S. Postal Service Delivery of Economic Impact Payments

Coronavirus Fraud Task Force Committed to Protecting U.S. Postal Service Delivery of Economic Impact Payments
Investigative Results |
Department of Justice OIG

United States Attorney McSwain, FBI Warn of Potential for Videoconferencing Hacking During Coronavirus Pandemic

Investigative Results |
Department of Justice OIG

Kentucky U.S. Attorneys Robert Duncan and Russell Coleman join Kentucky Attorney General Cameron in Launching PSA Warning about Fraudulent COVID-19 Testing Sites

Investigative Results |
Department of Justice OIG

$1.6+ Million in DOJ Grants For Public Safety in Response to COVID-19

$1,648,580 in federal grant dollars is now available to multiple communities across the Middle District of Georgia in response to the public safety challenges posed by the outbreak of COVID-19.
Investigative Results |
Government Accountability Office

GAO’s Coronavirus Oversight

An ongoing review of the federal response to the COVID-19 pandemic and oversight of related spending.